![Asylia Announces Formation of Distinguished Scientific Advisory Board](https://asyliatx.com/wp-content/uploads/2021/07/asylia-announces-formation-2.jpg)
Asylia Announces Formation of Distinguished Scientific Advisory Board
HOUSTON, July 22, 2021 – Asylia Therapeutics (“Asylia”), a development-stage biotechnology company advancing novel immune modulating therapies for cancer and autoimmune diseases, today announced the